https://scholars.lib.ntu.edu.tw/handle/123456789/543783
標題: | A double-blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan | 作者: | Chuang Y.-C. Lin C.-C. PO-MING CHOW Lien C.-S. Tsui K.-H. Chou C.-L. Lee H.-Y. Meng E. Kuo H.-C. |
關鍵字: | adverse events; antimuscarinics; overactive bladder; pharmacotherapy | 公開日期: | 2021 | 出版社: | Blackwell Publishing | 卷: | 13 | 期: | 1 | 起(迄)頁: | 108-117 | 來源出版物: | LUTS: Lower Urinary Tract Symptoms | 摘要: | Objective: This study evaluated the efficacy and safety of imidafenacin 0.1 mg twice daily vs placebo for Taiwanese patients with overactive bladder (OAB) after a 12-week oral administration. Methods: This randomized, double-blind, placebo-controlled, two |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089827867&doi=10.1111%2fluts.12341&partnerID=40&md5=b9e9fca57f2f3b762a0094b2959ff2c1 https://scholars.lib.ntu.edu.tw/handle/123456789/543783 |
ISSN: | 1757-5664 | DOI: | 10.1111/luts.12341 | SDG/關鍵字: | imidafenacin; placebo; imidafenacin; imidazole derivative; urinary tract agent; adult; allergic conjunctivitis; Article; backache; constipation; controlled study; diarrhea; double blind procedure; drug efficacy; drug safety; drug screening; dry eye; femal |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。